Tyrosine Kinase

Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
N2031 PiceatannolSummary: p56lck/Syk inhibitor -
A3256 BMS-690514Summary: HER/EGFR inhibitor -
A3750 Regorafenib hydrochlorideTarget: Raf|VEGFR|PDGFR|c-Kit|c-RETSummary: Tyrosine kinase inhibitor -
A4513 Lestaurtinib1 CitationSummary: JAK2/FLT3/TrkA inhibitor -
A5092 JNJ-38877605Summary: C-Met inhibitor,ATP-competitive -
A8393 CH5424802Target: ALKSummary: ALK inhibitor,potent and ATP-competitive -
A8606 PD 180970Summary: P210bcr/abl tyrosine kinase inhibitor -
A8684 ZM 306416Summary: VEGFR (Flt and KDR) inhibitor -
B6996 Ro 08-2750Summary: antagonist of nerve growth factor (NGF) -
B6161 PRT-060318Summary: novel Syk inhibitor
